AtriCure to Announce Second Quarter 2023 Financial Results
03 July 2023 - 10:00PM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments and therapies for atrial fibrillation (Afib), left
atrial appendage (LAA) management, and post-operative pain
management, today announced that it will release second quarter
2023 financial results on Tuesday, July 25, 2023.
AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on
Tuesday, July 25, 2023, to discuss its second quarter 2023
financial results. Those interested in listening to the conference
call should register online using this link. Participants are
encouraged to register more than 15 minutes before the start of the
call. A live and replay version of the audio webcast will be
available at
https://ir.atricure.com/events-and-presentations/events.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 37
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first medical
device to receive FDA approval for the treatment of persistent
Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System
products are the most widely sold LAA management devices worldwide.
AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure
that provides a lasting solution for long-standing persistent Afib
patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for
temporary ablation of peripheral nerves to block pain, providing
pain relief in cardiac and thoracic procedures. For more
information, visit AtriCure.com or follow us on Twitter
@AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230703954608/en/
Angie Wirick AtriCure, Inc. Chief Financial Officer (513)
755-5334 awirick@atricure.com
Lynn Lewis or Marissa Bych Gilmartin Group Investor Relations
lynn@gilmartinir.com marissa@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Nov 2024 to Dec 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Dec 2023 to Dec 2024
